908 Devices Inc
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of… Read more
908 Devices Inc (MASS) - Total Liabilities
Latest total liabilities as of December 2025: $46.37 Million USD
Based on the latest financial reports, 908 Devices Inc (MASS) has total liabilities worth $46.37 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
908 Devices Inc - Total Liabilities Trend (2018–2025)
This chart illustrates how 908 Devices Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
908 Devices Inc Competitors by Total Liabilities
The table below lists competitors of 908 Devices Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
iOCO Limited
JSE:IOC
|
South Africa | R2.37 Billion |
|
Dar Global Plc
LSE:DAR
|
UK | $1.48 Billion |
|
Brii Biosciences Limited
PINK:BRIBF
|
USA | $51.48 Million |
|
Beijing Telesound Electronics Co Ltd
SHE:003004
|
China | CN¥654.92 Million |
|
BV Financial, Inc. Common Stock
NASDAQ:BVFL
|
USA | $728.41 Million |
|
Zhejiang Meishuo Electric Technology Co. Ltd. A
SHE:301295
|
China | CN¥327.67 Million |
|
Richardson Electronics Ltd
NASDAQ:RELL
|
USA | $43.29 Million |
|
UNISEM Co. Ltd
KQ:036200
|
Korea | ₩42.73 Billion |
Liability Composition Analysis (2018–2025)
This chart breaks down 908 Devices Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how 908 Devices Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for 908 Devices Inc (2018–2025)
The table below shows the annual total liabilities of 908 Devices Inc from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $46.37 Million | +3.32% |
| 2024-12-31 | $44.88 Million | +19.72% |
| 2023-12-31 | $37.49 Million | -27.89% |
| 2022-12-31 | $51.99 Million | +12.28% |
| 2021-12-31 | $46.30 Million | +16.38% |
| 2020-12-31 | $39.79 Million | -60.54% |
| 2019-12-31 | $100.83 Million | +29.40% |
| 2018-12-31 | $77.92 Million | -- |